¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Cancer gene therapy."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • vaccine therapy
    ¹é½Å¿ä¹ý
  • will therapy
    ÀÇÁö¿ä¹ý
  • autosomal gene
    º¸Åë¿°»öüÀ¯ÀüÀÚ
  • additive gene
    »ó°¡À¯ÀüÀÚ
  • allelic gene
    ´ë¸³À¯ÀüÀÚ
  • complementary gene
    º¸Á·À¯ÀüÀÚ, »óÈ£º¸ÃæÀ¯ÀüÀÚ
  • control gene
    Á¦¾îÀ¯ÀüÀÚ
  • cooperating gene
    Çùµ¿À¯ÀüÀÚ
  • catabolite (gene) activator protein
    ºÐÇØ´ë»ç»ê¹°(À¯ÀüÀÚ)Ȱ¼º´Ü¹éÁú
  • calcitonin gene-related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • candidate gene
    Èĺ¸À¯ÀüÀÚ
  • duplicate gene
    º¹»çÀ¯ÀüÀÚ
  • determinant gene
    °áÁ¤À¯ÀüÀÚ
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • gene
    À¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • compression therapy
    ¾Ð¹Ú¿ä¹ý
  • conformal dynamic therapy
    ÀÔüÁ¶Çüµ¿Àû¿ä¹ý
  • conformal radiation therapy
    ÀÔüÁ¶Çü¹æ»ç¼±¿ä¹ý
  • conjoint therapy
    ÇÕµ¿¿ä¹ý
  • consolidation therapy
    °­È­¿ä¹ý
  • convulsive shock therapy
    °æ·ÃÃæ°Ý¿ä¹ý
  • corrective therapy
    ±³Á¤¿ä¹ý
  • couples therapy
    ºÎºÎ¿ä¹ý
  • curative radiation therapy
    Ä¡À¯¹æ»ç¼±Ä¡·á, ±ÙÄ¡¹æ»ç¼±¿ä¹ý
  • diathermic therapy
    Åõ¿­¿ä¹ý
  • didactic group therapy
    ±³À°Áý´Ü¿ä¹ý
  • directive group therapy
    Áö½ÃÁý´Ü¿ä¹ý
  • drug therapy
    ¾à¹°¿ä¹ý
  • electoconvulsive therapy
    Àü±â°æ·Ã¿ä¹ý
  • electric shock therapy
    Àü±âÃæ°Ý¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • immunization therapy
    ¸é¿ª¿ä¹ý(¸é¿ª¿ä¹ý).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý(¡­åäð¤èþÛö).
  • immunosuppressive therapy
    ¸é¿ª¾ïÁ¦¿ä¹ý
  • implosive therapy
    ³»ÆÄ Ä¡·á
  • inhalation therapy =i. treatment
    ÈíÀÔ ¿ä¹ý.
  • insulin shock therapy
    Àν¶¸°¼ï¿ä¹ý.
  • insulin therapy
    Àν¶¸°Ä¡·á, Àν¶¸°¿ä¹ý.
  • intensification therapy
    Áõ°­¿ä¹ý.
  • intensity modulated radiation therapy
    °­µµº¯Á¶ ¹æ»ç¼±Ä¡·á
  • photodynamic therapy
    ±¤¼±¿ªÇпä¹ý
  • photodynamic therapy
    ±¤¿ªÇÐÄ¡·á
  • physical therapy
    ¹°¸®Ä¡·á,¹°¸®¿ä¹ý
  • physical therapy technician
    ¹°¸® ¿ä¹ý ±â»ç(ÚªìµèþÛöÐüÞÔ).
  • play therapy
    ³îÀÌ¿ä¹ý,³îÀÌÄ¡·á,À¯Èñ¿ä¹ý.
  • postmenopausal hormone therapy
    Æó°æ±â È£¸£¸ó Ä¡·á
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • subglottic cancer
    ¼º¹®ÇϾÏ
  • subglottic cancer
    ¼º¹®ÇϾÏ(á¢Ú¦ù»äß)
  • tongue cancer
    ¼³¾Ï
  • ulcer-cancer
    ±Ë¾ç¾Ï(±Ë¾ç¾Ï).
  • ulcer-cancer
    ±Ë¾ç¾Ï(Ï÷åËäß)
  • ureteral cancer
    ¿ä°ü¾ÏÁ¾
  • uterine cancer
    ÀڱþÏ(í­Ïà ).
  • vaginal cancer
    Áú¾Ï
  • water cancer =gangrenous stomatitis
    ¼ö¾Ï(â©äß) ±«»ç¼º±¸³»¿°(ÎÕÞÝàõÏ¢Ò®æú)
  • additive gene
    »ó°¡À¯ÀüÀÚ(ßÓÊ¥ë¶îîí­).
  • allelic gene
    ´ë¸³À¯ÀüÀÚ
  • aniridia,pax-6 gene
    PAX-6 À¯ÀüÀÚ(¡­ë¶îîí­)
  • apc gene
    APC À¯ÀüÀÚ(¡­ë¶îîí­)
  • atk gene
    atk À¯ÀüÀÚ(¡­ë¶îîí­)
  • autosomal gene
    º¸Åë¿°»öüÀ¯ÀüÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • overlapping gene
    Áßø(ñìôá) À¯ÀüÀÚ(ë¶îîí­)
  • PET gene
    PET À¯ÀüÀÚ(ë¶îîí­)
  • polymorphic gene
    ´ÙÇü À¯ÀüÀÚ(Òýúþë¶îîí­)
  • positive gene control
    "°¡À¯ÀüÀÚÁ¶Àý(ʦë¶îîí­ðàï½), ¾ç¼ºÀ¯ÀüÀÚÁ¶Àý, (åÕàõë¶îîí­ðàï½)"
  • processed gene
    °¡°ø À¯ÀüÀÚ(Ê¥Íïë¶îîí­)
  • promoter gene
    ÇÁ·Î¸ðÅÍ À¯ÀüÀÚ(ë¶îîí­)
  • ras gene
    ras À¯ÀüÀÚ(ë¶îîí­)
  • recessive gene
    ¿­¼º À¯ÀüÀÚ(Ö«àõë¶îîí­)
  • recessive lethal gene
    ¿­¼º Ä¡»çÀ¯ÀüÀÚ(Ö«àõöÈÞÝë¶îîí­)
  • reciprocal gene
    »óº¸ À¯ÀüÀÚ(ßÓÜÍë¶îîí­)
  • regulator gene
    Á¶Àý À¯ÀüÀÚ(ðàï½ë¶îîí­)
  • repeated gene family
    ¹Ýº¹ À¯ÀüÀÚ °¡Á·(ë¶îîí­Ê«ðé)
  • repetitive gene
    ¹Ýº¹ À¯ÀüÀÚ(ë¶îîí­)
  • restriction gene
    Á¦ÇÑ À¯ÀüÀÚ(ë¶îîí­)
  • R gene
    R À¯ÀüÀÚ(ë¶îîí­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
CMGT chromosome-mediated gene transfer
CRYG gamma crystallin gene
din damage inducible [gene]
DMGT deoxyribonucleic acid-mediated gene transfer
FHIT fragile histidine triad [gene]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
HOT Home Oxygen Therapy
HRT Hormonal Replacement Therapy
HRT Hormone Replacement Therapy
HBO Hyperbaric Oxygen Therapy
HBOT Hyperbaric oxygen therapy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • light therapy
    ±¤¼± Ä¡·á
  • microwave therapy
    ±ØÃÊ´ÜÆÄ ¿ä¹ý
    ÆÄÀå 1 m ÀÌÇÏ, 1 mm ÀÌ»óÀÇ ÀüÀÚÆÄ¸¦ ÀÌ¿ëÇÏ´Â Àü±â¿ä¹ý. ¸¶ÀÌÅ©·Î¿þÀÌºê ¿ä¹ý , ¸¶ÀÌÅ©·ÎÆÄ ¿ä¹ýÀ̶ó°íµµ ÇÑ´Ù. º¸Åë ÀÇ·á¿ë¿¡´Â 12.5 cmÀÇ ÆÄÀåÀÌ Ã¤¿ëµÇ°í ÀÖ´Ù. ¸¶±×³×Æ®·ÐÀ̶ó´Â Áø°ø°ü¿¡¼­ ¹ßÁøµÇ¾î ¹Ý¿øÇü ¶Ç´Â °¢ÇüÀÇ Á¶»ç ÀåÄ¡·Î 5~10 cmÀÇ °Å¸®¿¡¼­ ȯºÎ¸¦ Á¶»çÇÑ´Ù. ÀÎü¿¡ Á¶»çÇÏ¿´À» ¶§ 3~4 cm¿¡¼­ ´ëºÎºÐ Èí¼öµÇ°í, ±× ¿¡³ÊÁö´Â ¿­·Î º¯ÇÑ´Ù. Áï, ½É´Þ¼ºÀº ÃÊ´ÜÆÄº¸´Ù ÀÛ°í Àû¿Ü¼±º¸´Ù´Â Å©´Ù. ±×·¸°Ô ±íÁö ¾ÊÀº Á¶Á÷¿¡ ´ëÇÑ ¿Â¿­¿ä¹ýÀ¸·Î ¾²À̸ç, ³ú, ´«, °íȯ µî°ú °°ÀÌ Ç÷ÇàÀÌ ÀûÀº ±â°ü¿¡¼­´Â °ú¿­µÉ À§ÇèÀÌ ÀÖÀ¸¹Ç·Î Á¶»çÇÒ ¶§ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
  • music therapy
    À½¾Ç ¿ä¹ý
  • non-reversible therapy
    ºñ°¡¿ªÀûÀÎ Ä¡·á
  • nonvital pulp therapy technique
    ½ÇȰ Ä¡¼ö Ä¡·á ¼ú½Ä
  • occlusal splint therapy
    ±³ÇÕ ÀåÄ¡ ¿ä¹ý
  • occlusal therapy
    ±³ÇÕ Ä¡·á
  • occupational therapy
    ÀÛ¾÷ ¿ä¹ý
    Ä¡·á ¸ñÀûÀ» À§ÇÑ ÀÛ¾÷ÀÇ Àû¿ë.
  • palliative therapy
    °í½ÄÀû Ä¡·á
  • prosthodontic therapy
    º¸Ã¶ Ä¡·á
  • radiation therapy
    ¹æ»ç¼± Ä¡·á
    °í¿¡³ÊÁö ¹æ»ç¼±À¸·Î ¾Ï ¼¼Æ÷¸¦ Á×À̰ųª ¼Õ»ó½ÃŰ´Â Ä¡·á¹ý. ¿ÜºÎ ¹æ»ç¼± Ä¡·á´Â °í¿¡³ÊÁö ¹æ»ç¼±À» ü¿Ü¿¡¼­ ¾Ï¿¡ Á¶ÁØÇÏ¿© ÂÉÀÌ´Â °ÍÀÌ´Ù. ³»ºÎ ¹æ»ç¼± Ä¡·á´Â ¹æ»ç¼º ¹°ÁúÀ» ü³» ¾Ï °¡±î¿î °÷¿¡ ³Ö¾î Ä¡·áÇÏ´Â °ÍÀÌ´Ù.
  • radioactive iodine therapy
    ¹æ»ç¼± Ȱ¼º ¿ä¿Àµå Ä¡·á
  • reality therapy
    Çö½Ç Ä¡·á
  • rehabilitative therapy
    ÀçÆÈ ¿ä¹ý
  • reversible occlusal therapy
    °¡¿ªÀûÀÎ ±³ÇÕ Ä¡·á, °¡¿ªÀû ±³ÇÕ Ä¡·á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
conjugal cancer Cancer a deux occurring in husband and wife.
Cancer a deux, carcinomas occurring at approximately the same time, or in fairly close succession, in two persons who live together.
Origin: Fr. Deux, two
(05 Mar 2000)
prostate cancer The second most common malignancy in men. A malignant tumour of glandular origin in the prostate. Over 95% are adenocarcinomas. Most commonly seen in older men, with the age of 73 being the average age at the time of diagnosis. A family history for prostate cancer and perhaps, a diet that is high is fat are considered to be risk factors for this malignancy. Early detection is possible through annual digital rectal examinations and routine PSA testing.
(27 Sep 1997)
scar cancer <tumour> Carcinoma of the lung, usually adenocarcinoma, arising from a peripheral lung scar or associated with interstitial fibrosis in a honeycomb lung.
Synonym: scar cancer.
(05 Mar 2000)
scar cancer of the lungs A pulmonary cancer intimately related to a localised area of parenchymal fibrosis; the cancer probably induces the fibrosis.
(05 Mar 2000)
Schridde's cancer hairs Thick lusterless hair's scattered in the beard and the temporal region, said to occur in cancerous patients but found also in persons with other cachectic conditions.
(05 Mar 2000)
secondary lung cancer The spread of cancerous tumours from a distant organ to the lung. Due to the lungs tremendous blood and lymphatic supply it is a frequent site for metastatic cancer. Cancers which commonly metastasize to the lung include osteosarcoma, breast cancer, neuroblastoma, Wilm's tumour and non-Hodgkin's lymphomas.
(27 Sep 1997)
skin cancer <oncology> A malignant growth on the skin.
Risk factors include: those who are fair-skinned or sunburn easily, freckled skin, blue or green eyes, blond or red hair, multiple moles, multiple bad sunburns in the past (particularly as a child) and a prior history for a skin cancer.
(27 Sep 1997)
small cell lung cancer A type of lung cancer in which the cells are small and round. Also called oat cell lung cancer.
(12 Dec 1998)
somatic mutation theory of cancer That cancer is caused by a mutation or mutations in the body cells (as opposed to germ cells), especially nonlethal mutations associated with increased proliferation of the mutant cells.
(05 Mar 2000)
spider cancer An obsolete term for a malignant neoplasm with a rhizoid or filamentous edge of thin, threadlike, red lines that represent dilated vascular channels associated with the neoplasm; a form of telangiectatic cancer.
(05 Mar 2000)
National Cancer Information Service <address, organisation> National Cancer Institute, cancer Information Service, office of Cancer Communications, Building 31, Room 10A24, 9000 Rockville Pike, Bethesda, MD 20892
(27 Sep 1997)
stomach cancer Cancer of the major organ that holds food for digestion. Stomach cancer (gastric cancer) can develop in any part of the stomach and spread to other organs. Stomach ulcers do not appear to increase a person's risk of developing stomach cancer. Symptoms of stomach cancer are often vague, such as loss of appetite and weight. The cancer is diagnosed with a biopsy of stomach tissue during a procedure.
(12 Dec 1998)
stomach cancer-associated protein-tyrosine phosphatase <enzyme> Human transmembrane-type ptpase expressed in gastric, pancreatic and colourectal cancer cells; consists of 1093 amino acid; mw 200 kD; genbank d15049
Registry number: EC 3.1.3.-
Synonym: sap 1 phosphatase
(26 Jun 1999)
stump cancer Carcinoma of the stomach developing after gastroenterostomy or gastric resection for benign disease.
(05 Mar 2000)
nonmelanoma skin cancer <oncology> Skin cancer that does not involve melanocytes. Basal cell cancer and squamous cell cancer are nonmelanoma skin cancers.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á